elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26775011-0B3908F8-D791-400E-869E-C1B919C82A2E
Q26775011-0B3908F8-D791-400E-869E-C1B919C82A2E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775011-0B3908F8-D791-400E-869E-C1B919C82A2E
Chronic hepatitis C: This and the new era of treatment
P2860
Q26775011-0B3908F8-D791-400E-869E-C1B919C82A2E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775011-0B3908F8-D791-400E-869E-C1B919C82A2E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7d7f5410d1f0121d345f27fd0978b7bcbd69e42c
P2860
Simeprevir with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial.